Monday, October 04, 2021 8:26:51 AM
Gladys Berejiklian, Premier of New South Wales has just resigned due to corruption investigation.
Clive Palmer, who is the most powerful unelected politician in Australia, (he's got $zillions of his own FU money and can say more or less what he wants if it's true), said said two weeks ago at a press conference about Berejiklian,
“Because as I tried to explain to you, she’s being directed by a lobbyist in Sydney who’s being paid by Astra Zeneca and by Pfizer tens of millions of dollars to get these policies through, to make sure these vaccines are pushed. That’s why. You asked the question and that’s my personal knowledge and I’m happy to make the statement here to the police or anyone who want to know what’s going on … I’ll be doing that. They’ll be named.”
Read in Cairns News and listen to presser here:
cairnsnews.org
So here she is resigning yesterday/today:
If big pharma is spending $millions in NSW, then what the hell are they spending in the big places?
Clive Palmer reminds me of Trump
Clive Palmer, who is the most powerful unelected politician in Australia, (he's got $zillions of his own FU money and can say more or less what he wants if it's true), said said two weeks ago at a press conference about Berejiklian,
“Because as I tried to explain to you, she’s being directed by a lobbyist in Sydney who’s being paid by Astra Zeneca and by Pfizer tens of millions of dollars to get these policies through, to make sure these vaccines are pushed. That’s why. You asked the question and that’s my personal knowledge and I’m happy to make the statement here to the police or anyone who want to know what’s going on … I’ll be doing that. They’ll be named.”
Read in Cairns News and listen to presser here:
cairnsnews.org
So here she is resigning yesterday/today:
If big pharma is spending $millions in NSW, then what the hell are they spending in the big places?
Clive Palmer reminds me of Trump
Recent RVVTF News
- Revive Therapeutics Announces Strategic Expansion of Bucillamine Program Across Infectious Diseases, Defence and Biothreat Medical Countermeasures • ACCESS Newswire • 05/20/2026 11:45:00 AM
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
